UCMSC ( DrugBank: - )

---

2 diseases

ID	Disease name (Link within this page)	Number of trials
51	Scleroderma	1
94	Primary sclerosing cholangitis	1

51. Scleroderma

---

Clinical trials : 525 /  Drugs : 565 - (DrugBank : 148) / Drug target genes : 114 - Drug target pathways : 217

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04356287 (ClinicalTrials.gov)	January 5, 2023	15/4/2020	Treatment With Human Umbilical Cord-derived Mesenchymal Stromal Cells in Systemic Sclerosis	Phase I/II Randomized Controlled Trial of Umbilical Cord-derived mesenChymAl stRomal cElls in Systemic Sclerosis	Sclerosis, Systemic;Mesenchymal Stem Cells	Biological: UCMSC;Other: Placebo	Marie Hudson, MD	Medical University of South Carolina;McGill University Health Centre/Research Institute of the McGill University Health Centre;Université de Montréal;Assistance Publique - Hôpitaux de Paris;Centre hospitalier de l'Université de Montréal (CHUM);University Paris 7 - Denis Diderot	Recruiting	18 Years	N/A	All	18	Phase 1/Phase 2	Canada

94. Primary sclerosing cholangitis

---

Clinical trials : 148 /  Drugs : 118 - (DrugBank : 39) / Drug target genes : 18 - Drug target pathways : 141

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03516006 (ClinicalTrials.gov)	January 2017	20/9/2017	Umbilical Cord Mesenchymal Stem Cells in Primary Sclerosing Cholangitis	Intra-arterial Injection of Umbilical Cord Mesenchymal Stem Cells in Primary Sclerosing Cholangitis	Primary Sclerosing Cholangitis	Drug: UCMSC;Drug: UDCA	Fuzhou General Hospital	NULL	Active, not recruiting	18 Years	65 Years	All	20	Phase 1/Phase 2	NULL